Engineering antibodies and antibody /cytokine fusion proteins for the treatment of human malignancies 

A single cell time course of senescence uncovers discrete cell trajectories and transcriptional heterogeneity 

Developing peptide and antibody-mimetic ligands for the cell surface receptors β2AR and DC-SIGN 

PD-L1-GM-CSF fusion protein-loaded DC vaccination activates PDL1-specific humoral and cellular immune responses 

Phosphorylation kinetics of T-cell receptor signaling domain in vitro 

Amelogenin domains in a self-assembly process 

Study of integrin αIIbβ3 transmembrane and cytosolic domain interaction and the expression of extracellular domain by Pichia Pastoris 

Engineering chimeric antigen receptor (CAR) -modified T cells for enhanced cancer immunotherapy 

Generation of disulfide-free antibody mimetics against the RAS protein 

Systematic analysis of single nucleotide polymorphisms in the human steroid 5-alpha reductase type I gene 

The mechanism of mammalian immunoglobulin class switch recombination: R-loop structures and activation-induced deaminase site preferences 

The mechanism of mammalian immunoglobulin class switch recombination 

mRNA display as a method to generate stable fibronectin ligands for the alpha 1 subunit of the nicotinic acetylcholine receptor 

Expression and purification of extracellular domain of human CD33 in Escherichia coli and Pichia pastoris 

Imaging and prodrug -activating derivatives of chTNT-3 (tumor necrosis therapy) monoclonal antibody 

Tumor necrosis therapy–interleukin-12 fusion proteins and cancer therapy 

Study of dendritic cell-specific lentivector vaccine system 

Three antibody-based immunotherapeutic modalities for malignancies 

A novel pulse-chase paradigm to visualize the trafficking of transport vesicles in neurons 

Using chemical biology approaches to investigate the consequences of protein concentration and activity in cancer cells 

Optimization of genetically engineered monoclonal antibody and antibody /cytokine fusion proteins for the detection and immunotherapy of solid malignancies 

Stable expression of human B7-H4 in a mouse mammary tumor model as a target for cancer immunotherapy 

Lym-1 epitope targeted chimeric antigen receptor (CAR) T cells for the immunotherapy of cancer 

Vitronectin misfolding and aggregation: implications for the pathophysiology of age-related diseases 

Biochemical development and analysis of NAD⁺-related biomolecules